EUCTR2007-007273-23-NL进行中（未招募）不适用
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine combined with Protocolized Surgery in Resectable Gastric Cancer - DoCCS
Jeroen Bosch Hospital0 个研究点开始时间: 2007年12月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ib-IVa histological proven resectable gastric adenocarcinoma
- •WHO < or = 1
- •Age > or = 18 years
- •No prior radio- or chemotherapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Ia gastric cancer
- •Other histological type than adenocarcinoma
- •Distant metastases
- •Inoperable patients
- •Other current serious illness or medical conditions
- •Known hypersensitivity to Docetaxel/Taxotere
- •Pregnant or lactating women
研究者
相似试验
已完成
2 期
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer An IKZ-based phase II feasibility studygastric carcinoma100179901001799110017998gastric cancerNL-OMON31603Jeroen Bosch Ziekenhuis50
招募中
不适用
A study to investigate the feasibility of chemotherapy prior to surgery and protocolized surgery in resectable stomach cancer.Resectable/curable gastric cancerNL-OMON20157dr K. Bosscha, surgeondr J.F.M. Pruijt, oncologistdrs A.E. Dassen, resident in training for surgery50
招募中
2 期
eoadjuvant DOS treatment for advanced esophageal cancerEsophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45
进行中（未招募）
1 期
A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis®) in Patients with Localized Myxoid / Round Cell Liposarcomaocalized myxoid / round cell liposarcoma previously untreated with chemotherapy or radiationMedDRA version: 9.1Level: LLTClassification code 10024630Term: Liposarcoma non-metastaticEUCTR2007-000035-25-FRPharma Mar, S.A.22
进行中（未招募）
不适用
A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (YONDELIS®) in Patients with Localized Myxoid / Round Cell Liposarcomaocally advanced (Stage III) myxoid / round cell liposarcoma previously untreated with chemotherapy or radiationMedDRA version: 9.1Level: LLTClassification code 10024630Term: Liposarcoma non-metastaticEUCTR2007-000035-25-DEPharma Mar, S.A.22